EARLIER ACCESS TO INNOVATION: ADAPTIVE LICENSING COMBINED WITH RISK SHARING - INTERIM RESULTS
- In: What’s new in industry and science? Part 2 on Thursday, 26 September 2019, 11:00-11:10
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Presentation
- By: HOLBEIN, Baerbel (University of Bremen, Duale Hochschule Baden-Württemberg, Germany)
- Co-author(s): Baerbel Holbein: University of Bremen, Duale Hochschule Baden-Württemberg, Bremen, Bad Mergentheim, Germany
Risk sharing agreements (RSA) between pharmaceutical companies, health insurers and payers already exist. One crucial question is what a risk sharing model could look like if applied for the clinical trial program with adaptive licensing pathways.
Drugs recently approved by both FDA and EMA, particularly the new CAR T.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.